As the continuous dengue outbreak that is happening in most areas in the Philippines, it was now approved in the country the vaccine that been needed to save thousands of lives.Dengvaxia, manufactured by French pharmaceutical giant Sanofi, secured its first regulatory approval in Mexico a fortnight ago and is currently being reviewed by around 20 countries in Asia and Latin America.

It is hoped the drug could eventually help prevent millions of deaths from dengue, the world’s fastest-growing mosquito-borne disease.The World Health Organization says as many as 400 million people are infected worldwide every year, and two-thirds are in Asia.

“It’s a major step in the prevention of dengue and for public health,” Olivier Charmeil, head of Sanofi’s vaccines division, said in a statement.

Through this vaccine, we are hoping that the number of people that died due to dengue might decrease and lessen. Lots of childrens and adults can use this vaccine.